Department of Surgery, Umeå University Hospital
Umeå, Sweden
NCT Number: NCT07814326
This investigation aims to demonstrate the feasibility of the lbFNA device for the first time in pancreatic cysts in humans. This study will be used as a base for further investigations on the safety and diagnostic accuracy of the lbFNA device.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Umeå, Sweden
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Loop Brush Fine Needle Aspiration (lbFNA) device is an endoscopy instrument used in this investigation for the puncture, brushing and aspiration of pancreatic cystic lesions prior to surgical removal of the pancreatic cystic lesion.
Time frame: From start of the lbFNA procedure until completion of the lbFNA procedure.
Integrity of the device after withdrawing from the patient, evaluated according to a separate inspection protocol with special focus on the loop.
Contact information is provided by the study sponsor or research team.
Urban Arnelo
Other Gov
Acronym: PCLoop-Pilot
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07817602
Biliary Drainage, Digestive System Diseases
Limoges, France
View Trial DetailsNCT04381130
Digestive System Diseases, Digestive System Neoplasms
View Trial DetailsNCT07814859
Digestive System Diseases, Digestive System Neoplasms
Zhengzhou, Henan, China
View Trial DetailsNCT07814066
Digestive System Diseases, Digestive System Neoplasms
View Trial Details